APIM Therapeutics
is a Norway-based biotechnology company that researches and develops novel therapeutics for the treatment of cancer... Read moreAPIM Therapeutics
is a Norway-based biotechnology company that researches and develops novel therapeutics for the treatment of cancer... Read more
News
Oct 27, 2023
Pharamceutical Technology
APIM Therapeutics: ATX-101 by APIM Therapeutics for Leiomyosarcoma: Likelihood of Approval
Nov 30, 2022
Medthority
APIM Therapeutics: Nordic Nanovector to merge with APIM Therapeutics
Nov 10, 2022
Pharmaphorum
APIM Therapeutics: Nordic Nanovector to merge with APIM after Betalutin fail
Nov 10, 2022
FinanzNachrichten
APIM Therapeutics: Nordic Nanovector and APIM Therapeutics Announce Merger Agreement
Jan 13, 2022
Cision
Press Release: APIM Therapeutics : APIM THERAPEUTICS ANNOUNCEs PUBLICATION OF PRECLINICAL RESEARCH OF ATX-101 IN GLIOBLASTOMA
Dec 10, 2021
Cision
Press Release: APIM Therapeutics : APIM THERAPEUTICS ANNOUNCES INITIATION OF PATIENT RECRUITMENT IN A SARCOMA PHASE II STUDY
Nov 25, 2021
Cision
Press Release: APIM Therapeutics : APIM THERAPEUTICS ANNOUNCES THAT THE FIRST PATIENT HAS BEEN TREATED WITH ATX-101 IN A PHASE I/II OVARIAN CANCER STUDY
May 18, 2021
Cision
Press Release: APIM Therapeutics : APIM THERAPEUTICS COMPLETES PRIVATE PLACEMENT AND ENTERS PHASE-2 CLINICAL DEVELOPMENT
Jul 24, 2017
BioPortfolio
APIM Therapeutics: APIM Therapeutics AS Pharmaceuticals Healthcare Deals and Alliances Profile. Report Updated 20072017 Prices from USD $250
Mar 28, 2017
BioPortfolio
APIM Therapeutics: APIM Therapeutics AS Pharmaceuticals Healthcare Deals and Alliances Profile Updated 22022017 Prices from USD $250
